CD44 and Hematologic Malignancies

被引：0
作者：
Liu, Jianing [1 ]
Jiang, Guosheng [1 ]
机构：
[1] Shandong Acad Med Sci, Inst Basic Med, Dept Hematol Oncol, Jinan 250062, Shandong, Peoples R China
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2006年 / 3卷 / 05期
关键词：
CD44; hematological malignancy; prognosis; therapy;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The expression of CD44 was upregulated in some hematological malignancies and is associated with metastasis and prognosis. The ligation of CD44 with specific monoclonal antibodies can trigger terminal differentiation of leukemic blasts in some subtypes, so it is probable to develop an anti-CD44 based differentiation therapy in leukemia. The effects of CD44 and its monoclonal antibodies are discussed in this review.
引用
收藏
页码：359 / 365
页数：7
相关论文
共 50 条
[41]   Targeting CD22 for B-cell hematologic malignancies [J].
Xu, Jia ;
Luo, Wenjing ;
Li, Chenggong ;
Mei, Heng .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[42]   CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer [J].
Hou, Weiyan ;
Kong, Lingwei ;
Hou, Zhiping ;
Ji, Hairu .
BMC MEDICAL GENOMICS, 2022, 15 (01)
[43]   Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma [J].
Gotoda, T ;
Matsumura, Y ;
Kondo, H ;
Ono, H ;
Kanamoto, A ;
Kato, H ;
Watanabe, H ;
Tachimori, Y ;
Nakanishi, Y ;
Kakizoe, T .
GUT, 2000, 46 (01) :14-19
[44]   Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia [J].
Amirghofran, Zahra ;
Asiaee, Elham ;
Kamazani, Fatemeh M. .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (03) :e375-e382
[45]   CD44 isoform expression in synovial sarcoma correlates with epitheliogenesis but not prognosis [J].
Sneath, RJ ;
Mangham, DC .
HISTOPATHOLOGY, 2000, 37 (02) :166-174
[46]   The role of CD44 in epithelial-mesenchymal transition and cancer development [J].
Xu, Hanxiao ;
Tian, Yijun ;
Yuan, Xun ;
Wu, Hua ;
Liu, Qian ;
Pestell, Richard G. ;
Wu, Kongming .
ONCOTARGETS AND THERAPY, 2015, 8 :3783-3792
[47]   CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer [J].
Weiyan Hou ;
Lingwei Kong ;
Zhiping Hou ;
Hairu Ji .
BMC Medical Genomics, 15
[48]   Expression of CD44 variants and its association with survival in pancreatic cancer [J].
Gotoda, T ;
Matsumura, Y ;
Kondo, H ;
Saitoh, D ;
Shimada, Y ;
Kosuge, T ;
Kanai, Y ;
Kakizoe, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (10) :1033-1040
[49]   CD44 enhances tumor aggressiveness by promoting tumor cell plasticity [J].
Paulis, Yvette W. J. ;
Huijbers, Elisabeth J. M. ;
van der Schaft, Daisy W. J. ;
Soetekouw, Patricia M. M. B. ;
Pauwels, Patrick ;
Tjan-Heijnen, Vivianne C. G. ;
Griffioen, Arjan W. .
ONCOTARGET, 2015, 6 (23) :19634-19646
[50]   Expression of CD44 in Leukocyte Subpopulations in Patients with Inflammatory Bowel Diseases [J].
Franic, Ivana ;
Rezic-Muzinic, Nikolina ;
Markotic, Anita ;
Zivkovic, Piero Marin ;
Vilovic, Marino ;
Rusic, Doris ;
Bozic, Josko .
DIAGNOSTICS, 2022, 12 (08)
12345